160 related articles for article (PubMed ID: 32719264)
1. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients.
Mahdavi SR; Rezaeyan A; Nikoofar A; Bakhshandeh M; Farahani S; Cheraghi S
J Cancer Res Ther; 2020; 16(3):539-545. PubMed ID: 32719264
[TBL] [Abstract][Full Text] [Related]
2. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Das N; Kaushal D; Patro SK; Pareek P; Dixit A; Soni K; Prakasan Nair N; Choudhury B; Goyal A
Acta Otolaryngol; 2021 Sep; 141(9):885-893. PubMed ID: 34486907
[TBL] [Abstract][Full Text] [Related]
3. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
4. Short-term cohort study on sensorineural hearing changes in head and neck radiotherapy.
Cheraghi S; Nikoofar P; Fadavi P; Bakhshandeh M; Khoie S; Gharehbagh EJ; Farahani S; Mohebbi A; Vasheghani M; Zare M; Nikoofar A; Mahdavi SR
Med Oncol; 2015 Jul; 32(7):200. PubMed ID: 26071124
[TBL] [Abstract][Full Text] [Related]
5. Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature.
Theunissen EA; Bosma SC; Zuur CL; Spijker R; van der Baan S; Dreschler WA; de Boer JP; Balm AJ; Rasch CR
Head Neck; 2015 Feb; 37(2):281-92. PubMed ID: 24478269
[TBL] [Abstract][Full Text] [Related]
6. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
[TBL] [Abstract][Full Text] [Related]
7. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
[TBL] [Abstract][Full Text] [Related]
8. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Rasch CR; Tange RA; Balm AJ; Dreschler WA
Audiol Neurootol; 2006; 11(5):318-30. PubMed ID: 16983183
[TBL] [Abstract][Full Text] [Related]
9. Cochlea CT radiomics predicts chemoradiotherapy induced sensorineural hearing loss in head and neck cancer patients: A machine learning and multi-variable modelling study.
Abdollahi H; Mostafaei S; Cheraghi S; Shiri I; Rabi Mahdavi S; Kazemnejad A
Phys Med; 2018 Jan; 45():192-197. PubMed ID: 29329660
[TBL] [Abstract][Full Text] [Related]
10. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
Chen WC; Jackson A; Budnick AS; Pfister DG; Kraus DH; Hunt MA; Stambuk H; Levegrun S; Wolden SL
Cancer; 2006 Feb; 106(4):820-9. PubMed ID: 16421885
[TBL] [Abstract][Full Text] [Related]
11. Radiation dose to the cochlea and its association with sensorineural hearing loss in head and neck cancer-A prospective study.
Apoorva KV; Vijendra Shenoy S; Athiyamaan MS; Kabekkodu S; Kshithi K; Zuturu N
Am J Otolaryngol; 2023; 44(4):103914. PubMed ID: 37178536
[TBL] [Abstract][Full Text] [Related]
12. Predicting Hearing Loss After Radiotherapy and Cisplatin Chemotherapy in Patients With Head and Neck Cancer.
Schuette A; Lander DP; Kallogjeri D; Collopy C; Goddu S; Wildes TM; Daly M; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):106-112. PubMed ID: 31750863
[TBL] [Abstract][Full Text] [Related]
13. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.
Scobioala S; Parfitt R; Matulat P; Kittel C; Ebrahimi F; Wolters H; Am Zehnhoff-Dinnesen A; Eich HT
Strahlenther Onkol; 2017 Nov; 193(11):910-920. PubMed ID: 28887665
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: a systematic review.
Mujica-Mota M; Waissbluth S; Daniel SJ
Head Neck; 2013 Nov; 35(11):1662-8. PubMed ID: 23280686
[TBL] [Abstract][Full Text] [Related]
15. Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era - The Early and Late Effects of Radiation and Cisplatin.
Yip PL; Mok KCJ; Ho HS; Lee WYV; Wong ACL; Lau CT; Wong FCS; Yeung KW; Lee SF
Clin Oncol (R Coll Radiol); 2022 Apr; 34(4):e160-e167. PubMed ID: 34772581
[TBL] [Abstract][Full Text] [Related]
16. Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood Cancer.
Bass JK; Hua CH; Huang J; Onar-Thomas A; Ness KK; Jones S; White S; Bhagat SP; Chang KW; Merchant TE
J Clin Oncol; 2016 Apr; 34(11):1248-55. PubMed ID: 26811531
[TBL] [Abstract][Full Text] [Related]
17. Factors Affecting Permanent Sensorineural Hearing Loss and Bone Conduction in Patients After Receiving Radiotherapy to the Head and Neck Region.
Yücel B; Erdiş E; Bahar S; Akkaş Atasever E; Celasun MG; Altuntaş EE
Turk Arch Otorhinolaryngol; 2022 Dec; 60(4):212-219. PubMed ID: 37456600
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.
Wei Y; Zhou T; Zhu J; Zhang Y; Sun M; Ding X; Wang D; Li H; Li B
Cell Biochem Biophys; 2014 Jul; 69(3):433-7. PubMed ID: 24510513
[TBL] [Abstract][Full Text] [Related]
19. Normal tissue complication probability modeling of radiation-induced sensorineural hearing loss after head-and-neck radiation therapy.
Cheraghi S; Nikoofar A; Bakhshandeh M; Khoei S; Farahani S; Abdollahi H; Mahdavi SR
Int J Radiat Biol; 2017 Dec; 93(12):1327-1333. PubMed ID: 28967273
[TBL] [Abstract][Full Text] [Related]
20. Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients.
Petsuksiri J; Sermsree A; Thephamongkhol K; Keskool P; Thongyai K; Chansilpa Y; Pattaranutaporn P
Radiat Oncol; 2011 Feb; 6():19. PubMed ID: 21333025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
